Cystic fibrosis

Cystic fibrosis
Cystic fibrosis One of the most beautiful pieces of information collected in this trial was the effect on the frequency of pulmonary exacerbations or periods when the disease worsening, Kauffman says. Although the ability to improve lung function is essential for pulmonary exacerbations in patients who often feel that the most disruptive: antibiotics should be switched to other drugs added, and may even lead to hospitalization. “These exacerbations are a tangible reminder of the disease,” Kauffman noted. The company was surprised that despite a relatively short trial, there was a marked decrease in the frequency of exacerbations: patients taking VX-770 were 55% less likely to experience exacerbation than placebo.